Interleukin 2 production in lymphocyte cultures: a rapid test for cancer-associated immunodeficiency in malignant cervical neoplasia

Peripheral blood lymphocytes of patients with malignant cervical neoplasia were studied for their capacity to produce interleukin-2 (IL-2) upon in vitro mitogen stimulation. Patients with early disease (Stage I IIA ) showed levels comparable to normal controls but those with advanced disease showed...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 47; no. 3; pp. 205 - 210
Main Authors Radhakrishna Pillai, M., Balaram, P., Bindu, S., Hareendran, N.K., Padmanabhan, T.K., Nair, M.K.
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 01.10.1989
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Peripheral blood lymphocytes of patients with malignant cervical neoplasia were studied for their capacity to produce interleukin-2 (IL-2) upon in vitro mitogen stimulation. Patients with early disease (Stage I IIA ) showed levels comparable to normal controls but those with advanced disease showed reduced levels, the reduction increasing with tumour load. These findings excellently correlated with our previous observations on a depressed cellular immunity in these patients. On follow up of the patients it was noticed that those who developed recurrent disease showed sustained lower levels of IL-2 production compared to those who remained disease free. These results stress the importance of a deranged immune system in these patients and also shows the clinical and prognostic value of such an assay.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0304-3835
1872-7980
DOI:10.1016/0304-3835(89)90092-X